About: Ellie J. C. Goldstein

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Ellie J. C. Goldstein Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
field of work	wds:Q124420119-2587e16f-b155-4c4b-a30c-37f97a031b7b wds:Q124420119-bb67c92c-913f-46d2-844c-e43df18245be wds:Q124420119-c1fc7b9c-1341-4134-b8ba-186ae205b4c0
field of work	medical microbiology medicine infectious diseases
description	researcher (en)
rdfs:label	Ellie J. C. Goldstein (cs) Ellie J. C. Goldstein (en)
skos:prefLabel	Ellie J. C. Goldstein (cs) Ellie J. C. Goldstein (en)
name	Ellie J. C. Goldstein (cs) Ellie J. C. Goldstein (en)
instance of	wds:Q124420119-F92BEA90-7AEB-465B-B7C3-1A88E4651C93
NL CR AUT ID	wds:Q124420119-d2f63b75-447d-f599-1ea9-d071c5187319
instance of	Homo sapiens
NL CR AUT ID	xx0236771
ResearchGate profile ID	wds:Q124420119-38b68159-4cf9-1f43-5003-77a5e90f59ee
ResearchGate profile ID	Ellie-Goldstein
Nationale Thesaurus voor Auteursnamen ID	wds:Q124420119-0520d61d-43f1-df4c-cd6d-67e99a794a8c
occupation	wds:Q124420119-5DB0ABD5-DABD-49C8-A69F-A94E1417FE02 wds:Q124420119-928ff732-2e3b-401d-8582-bc95f65b75dd wds:Q124420119-a7848bdf-64f5-4b6f-88c7-7a526809e5a6 wds:Q124420119-c65f1f53-1a54-4153-8edf-49a7af9167b2
languages spoken, written or signed	wds:Q124420119-c38915e5-81bf-45f9-89c5-d10bae87975b
National Library of Greece ID	wds:Q124420119-e43b9712-4f8f-1bda-5a17-1dd8e787d4db
Nationale Thesaurus voor Auteursnamen ID	http://data.bibliotheken.nl/id/thes/p109353420
National Library of Greece ID	http://data.nlg.gr/resource/authority/A282048
Nationale Thesaurus voor Auteursnamen ID	109353420
occupation	microbiologist physician researcher infectious disease physician
languages spoken, written or signed	English
National Library of Greece ID	282048
ORCID iD	wds:Q124420119-3819C2F1-498D-4D7B-965F-988DF4C01B10
ORCID iD	https://orcid.org/0000-0002-1044-6159
ORCID iD	0000-0002-1044-6159
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q124420119
is author of	Evaluation of a novel specimen transport system (Venturi Transystem) for anaerobic bacteria In vitro activities of ABT-492, a new fluoroquinolone, against 155 aerobic and 171 anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis Antimicrobial activities of fidaxomicin Activity of a novel carbapenem, doripenem, against anaerobic pathogens Diabetic foot infections. Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases. Molecular characterization and antimicrobial susceptibilities of extra-intestinal Clostridium difficile isolates In vitro activities of newer quinolones against bacteroides group organisms Bacteriologic analysis of infected dog and cat bites. Emergency Medicine Animal Bite Infection Study Group Occurrence of Bacteroides fragilis enterotoxin gene-carrying strains in Germany and the United States. National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997-2000. Bacteriology of human bite wound infections Characterization of the Bacteroides fragilis pathogenicity island in human blood culture isolates. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America Comparative in vitro activities of retapamulin (SB-275833) against 141 clinical isolates of Propionibacterium spp., including 117 P. acnes isolates IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults Practice guidelines for the diagnosis and management of skin and soft-tissue infections Clinical outcomes, safety, and pharmacokinetics of OPT-80 in a phase 2 trial with patients with Clostridium difficile infection 16S-23S rRNA gene internal transcribed spacer sequences for analysis of the phylogenetic relationships among species of the genus Porphyromonas. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America Beyond the target pathogen: ecological effects of the hospital formulary In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infections National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004 Intra-abdominal infections: review of the bacteriology, antimicrobial susceptibility and the role of ertapenem in their therapy. National hospital survey of anaerobic culture and susceptibility methods: III. In vitro activity of 11 antibiotics against 74 anaerobes isolated from pediatric intra-abdominal infections Identification and antimicrobial resistance patterns of clinical isolates of Clostridium clostridioforme, Clostridium innocuum, and Clostridium ramosum compared with those of clinical isolates of Clostridium perfringens Aetiology of antimicrobial-agent-associated colitis Comparative in vitro activities of GSK2251052, a novel boron-containing leucyl-tRNA synthetase inhibitor, against 916 anaerobic organisms A central role for venom in predation by Varanus komodoensis (Komodo Dragon) and the extinct giant Varanus (Megalania) priscus Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole. Comparative in vitro inhibitory and killing activity of cefpirome, ceftazidime, and cefotaxime against Pseudomonas aeruginosa, enterococci, Staphylococcus epidermidis, and methicillin-susceptible and -resistant and tolerant and nontolerant Staphyloc Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America Characterization of a beta-lactamase from Clostridium clostridioforme Microbiology of animal bite wound infections Staphylococcus intermedius in canine gingiva and canine-inflicted human wound infections: laboratory characterization of a newly recognized zoonotic pathogen Pathway to Prevention of Nosocomial Clostridium difficile Infection C. difficile infection (CDI) in a long-term acute care facility (LTAC). Role of anaerobic bacteria in bite-wound infections. Dog bite wounds and infection: a prospective clinical study Fusobacterium canifelinum sp. nov., from the oral cavity of cats and dogs Genetic determinant of intrinsic quinolone resistance in Fusobacterium canifelinum Bactericidal activities of methoxyfluoroquinolones gatifloxacin and moxifloxacin against aerobic and anaerobic respiratory pathogens in serum In vitro activities of the des-fluoro(6) Quinolone BMS-284756 against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections 16S-23S rDNA internal transcribed spacer sequences for analysis of the phylogenetic relationships among species of the genus Fusobacterium Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens. Desulfovibrio desulfuricans bacteremia and review of human Desulfovibrio infections Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007) Comparative in vitro activities of XRP 2868, pristinamycin, quinupristin-dalfopristin, vancomycin, daptomycin, linezolid, clarithromycin, telithromycin, clindamycin, and ampicillin against anaerobic gram-positive species, actinomycetes, and lactobac In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents against anaerobic gram-positive species and Corynebacterium spp In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria Antianaerobic antimicrobials: spectrum and susceptibility testing In vitro activity of ceftaroline against 623 diverse strains of anaerobic bacteria In vitro activities of daptomycin, vancomycin, and penicillin against Clostridium difficile, C. perfringens, Finegoldia magna, and Propionibacterium acnes Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009. Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America In vitro activities of dalbavancin and nine comparator agents against anaerobic gram-positive species and corynebacteria Comparative in vitro activities of dalbavancin and seven comparator agents against 41 Staphylococcus species cultured from osteomyelitis infections and 18 VISA and hVISA strains

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software